Showing results (11-20 of 278) with videos related to
Sort By:
Pageof 28
Current Medicinal Chemistry|October 18, 2000
Structural approaches to explain the selectivity of COX-2 inhibitors: is there a common pharmacophore?G Dannhardt, S LauferArchiv Der Pharmazie|March 1, 1993
Nonsteroidal antiinflammatory agents, XVII: Inhibition of bovine cyclooxygenase and 5-lipoxygenase by N-alkyldiphenyl-pyrrolyl acetic and propionic acid derivativesG Dannhardt, M LehrArchiv Der Pharmazie|June 23, 2000
Benzimidazoles as NMDA glycine-site antagonists: study on the structural requirements in 2-position of the ligandG Dannhardt, B K KohlCurrent Medicinal Chemistry|September 20, 2001
The NMDA receptor complex: a promising target for novel antiepileptic strategiesB K Kohl, G DannhardtCurrent Medicinal Chemistry|July 21, 1998
The glycine site on the NMDA receptor: structure-activity relationships and possible therapeutic applicationsG Dannhardt, B K KohlArchiv Der Pharmazie|August 31, 2000
Effect of flavonol derivatives on the carrageenin-induced paw edema in the rat and inhibition of cyclooxygenase-1 and 5-lipoxygenase in vitroA M Sobottka, W Werner, G Blaschke, et al.Archiv Der Pharmazie|December 13, 1997
Synthesis and evaluation of a novel series of pyrrolizine derivatives as dual cyclooxygenase-1 and 5-lipoxygenase inhibitorsS Laufer, H G Striegel, K Neher, et al.Archiv Der Pharmazie|March 1, 1997
Non-steroidal anti-inflammatory agents, Part 24. Pyrrolidino enaminones as models to mimic arachidonic acidG Dannhardt, A Bauer, U NoweArchiv Der Pharmazie|March 1, 1991
[Hypertensive action of 5-(beta-aminoethyl)aminoisoxazoles: synthesis and screening of isoxazolopyrazines and isoxazolodiazepines]G Dannhardt, P Dominiak, S LauferArzneimittel-Forschung|April 1, 1993
Hypertensive effects and structure-activity relationships of 5-omega-aminoalkyl isoxazolesG Dannhardt, P Dominiak, S LauferPageof 28